Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by ONCInvestoron Nov 09, 2023 8:14pm
250 Views
Post# 35727374

RE:RE:RE:Today’s Disaster

RE:RE:RE:Today’s DisasterToday was a gut-punch and there is no way to spin this otherwise.

After Bracelet, I had intended to decrease my holdings, but reversed course after the PanCAN announcement in June. I thought finally we were getting some traction on a P3. I am actually at a loss for words about this management team. That includes the board, btw, who are apparantly A-OK with management, (a) announcing a partnership, (b) providing a time-line for execution of agreements, (c) letting that time-line slip with no comment, and then (d) announcing a month-late that, in fact, there will be no partnership. 

I hope the board and management at least have the decency to be embarrassed by this amatuer-hour conduct.. I know I'm embarrased to be a shareholder.


<< Previous
Bullboard Posts
Next >>